Literature DB >> 3178285

Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy.

S Töyry1, J Fräki, R Tammi.   

Abstract

Numbers and volume fractions of mast cells in nonlesional and chronic lesional skin of psoriatic patients were compared with those of normal control skin. Mast cell densities were similar in psoriatic nonlesional and normal control skin. The superficial dermis of lesional psoriatic skin contained more mast cells than either normal or nonlesional psoriatic skin. Neither PUVA nor corticosteroid treatment for 3-4 weeks significantly reduced mast cell numbers or volume fractions in lesional skin, although both treatments clinically and histologically markedly improved the lesions. The results indicate that the initiation of the healing process in psoriatic plaques is not correlated with the mast cell density. The remaining high mast cell density may be normalized later, or after a longer therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3178285     DOI: 10.1007/bf00440601

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  Distribution of mast cells in human dermis: development of a mapping technique.

Authors:  T Cowen; P Trigg; R A Eady
Journal:  Br J Dermatol       Date:  1979-06       Impact factor: 9.302

Review 2.  [The dynamics of the mode of reactions of psoriatic skin].

Authors:  G K Steigleder
Journal:  Arch Klin Exp Dermatol       Date:  1966

3.  [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study].

Authors:  O Braun-Falco; G Burg
Journal:  Arch Klin Exp Dermatol       Date:  1970

4.  [Mast cells in skin altered by psoriasis--before, during and after cignolin therapy].

Authors:  H Schmitz
Journal:  Dermatol Wochenschr       Date:  1967-03-04

5.  Mast cells and macrophages in early relapsing psoriasis.

Authors:  C Schubert; E Christophers
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Role of the microcirculation in the treatment and pathogenesis of psoriasis.

Authors:  I M Braverman; J Sibley
Journal:  J Invest Dermatol       Date:  1982-01       Impact factor: 8.551

7.  Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations.

Authors:  G Kolde; P J Frosch; B M Czarnetzki
Journal:  J Invest Dermatol       Date:  1984-09       Impact factor: 8.551

8.  Treatment of urticaria pigmentosa with corticosteroids.

Authors:  J Barton; R M Lavker; N M Schechter; G S Lazarus
Journal:  Arch Dermatol       Date:  1985-12

9.  Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris.

Authors:  I Brody
Journal:  J Invest Dermatol       Date:  1984-05       Impact factor: 8.551

10.  Cutaneous mast cell depletion results from topical corticosteroid usage.

Authors:  R M Lavker; N M Schechter
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

View more
  8 in total

1.  Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique.

Authors:  A Naukkarinen; I T Harvima; M L Aalto; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.

Authors:  Andrew M Lin; Cory J Rubin; Ritika Khandpur; Jennifer Y Wang; MaryBeth Riblett; Srilakshmi Yalavarthi; Eneida C Villanueva; Parth Shah; Mariana J Kaplan; Allen T Bruce
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

3.  Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M L Aalto; H Neittaanmäki; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  Mast cell tryptase and chymase in developing and mature psoriatic lesions.

Authors:  I T Harvima; A Naukkarinen; K Paukkonen; R J Harvima; M L Aalto; L B Schwartz; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

5.  Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces.

Authors:  R Tammi; K Paukkonen; C Wang; M Horsmanheimo; M Tammi
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Enzyme- and immunohistochemical localization of mast cell tryptase in psoriatic skin.

Authors:  I T Harvima; A Naukkarinen; R J Harvima; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 7.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 8.  Current knowledge on psoriasis and autoimmune diseases.

Authors:  Nilmarie Ayala-Fontánez; David C Soler; Thomas S McCormick
Journal:  Psoriasis (Auckl)       Date:  2016-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.